Nimbus Apollo Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Nimbus Apollo General Information

Description

Developer of drugs. The company is engaged in research and development of various drugs that provides treatments for certain liver diseases such as non-alcoholic steatohepatitis (NASH) and others.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Gilead Sciences
Primary Office
  • 784 Memorial Drive
  • Suite 100
  • Cambridge, MA 02139
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nimbus Apollo Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nimbus Apollo‘s full profile, request access.

Request a free trial

Nimbus Apollo Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nimbus Apollo‘s full profile, request access.

Request a free trial